Rob Hooper, national sales manager for OTC with Actavis Pharmaceutical, sat down with DSN to discuss how Actavis is preparing for the inaugural NACDS Total Store Expo. Actavis Pharmaceutical, one of the leaders in the OTC private label industry and recently acquired by Watson Pharmaceutical, plans to leverage its extensive experience within the prescription medicine business to offer best-in-class options across store brand products.
Hikma Pharmaceuticals on Wednesday announced its acquisition of Roxane Laboratories and Boehringer Ingelheim Roxane (together, “Roxane” — an American specialty generics company) from Boehringer Ingelheim for about $2.65 billion.
From the leadership team in Camp Hill, Pa., to the nearly 90,000 associates it has in the field and in its stores, they believe in themselves and have built a culture focused on finding and implementing the next big idea, and creating important differentiation from their competitors.
Rite Aid has its merchandising strategy down to a fine science. Even as the merchant team reporting to Tony Montini, Rite Aid EVP of merchandising, delivers a standardized shopping experience to Rite Aid customers, the company’s merchants are constantly experimenting with new ideas that help differentiate that shopping experience from the store across the street.
More and more, the success of any healthcare delivery model in the United States will depend on the ability of all members of a patient-care team — physicians, pharmacists, hospital systems and health plan payers included — to collaborate effectively on a longterm plan of care that’s focused on successful outcomes and disease prevention.
Mergers and acquisitions among pharmaceutical companies has kicked into high gear this year, mirroring the larger trend sweeping across the entire spectrum of the health care industry since the implementation of the Affordable Care Act two years ago.